Friday, December 27, 2019 11:52:40 PM
The Dr. at the admitting facility didn't do what was right, as they previously hadn't been paid when they did, and they were told to accept the insurers guidance which was coming from an accountant there. It turned out the patient had a history of illness all her 8 year life, but a relatively cheap test had never been run by the Doctors for the insurance company, which would have shown she was born without a spleen, a very rare condition. In the end, the Jury made a substantial award with the majority coming from the insurer, but both had some guilt. The doctor at the admitting facility attempted to do what was right, but essentially accountants at both facilities had more to say about what he should, and shouldn't do then the medical staff.
One of the things I really like about City of Hope is they seem to do what's best for the patient, than they fight if necessary to get paid for what they do. A few prescriptions they wanted me on took a few days to get approval, but they never substituted to something the insurance company demanded. As the patient they never really told me of the problems, I just knew it would be a few days, and that was how long it took.
I know of at least a few cases where personalized medications were made there, including modifying T-cells from the patient to fight a particular form of leukemia. My treatment has shown no sign of the leukemia since stem cells were given about four and a half years ago. Potentially I could come off chemo at 5 years, but yesterday in discussing it with my Dr. I probably won't, but perhaps will cut down. Before the stem cells my numbers bobbled, it concerned him enough to believe that even after five years they might do so again. He assured me their were better ways of treating me today if I came out of remission, but he indicated it's not something he wanted to put me through, so I'll probably err on the side of caution.
Gary
Recent NWBO News
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM